NRF2 has promising prospects as a novel target for the treatment of neurodegenerative diseases, since Alzheimer’s disease is closely related to oxidative stress, mitochondrial dysfunction, and ferroptosis. This evidence concerns the gene NFE2L2 and early-onset autosomal dominant Alzheimer disease.